Key Takeaways
- • GrowthCurve Capital has taken a majority stake in TailorMed, a US-based medication access platform, according to PE Hub.
- • TailorMed operates a platform designed to help patients access, afford and stay on prescribed medications.
- • The source does not disclose deal value, seller identity, or financial terms of the transaction.
Summary
GrowthCurve Capital has acquired a majority stake in TailorMed, a healthcare company that runs a medication access platform, according to a brief published by PE Hub. The deal is categorized as a North American healthcare transaction in the US.
TailorMed's platform helps patients access, afford and stay on prescribed medications, a function that sits within the broader US pharmacy and patient support services market. The source report is brief and does not disclose the transaction value, the size of the stake acquired beyond the term majority, or the identities of any selling shareholders. Further detail on the deal's financial terms and strategic rationale was not available in the source material.
TailorMed's platform helps patients access, afford and stay on prescribed medications, a function that sits within the broader US pharmacy and patient support services market. The source report is brief and does not disclose the transaction value, the size of the stake acquired beyond the term majority, or the identities of any selling shareholders. Further detail on the deal's financial terms and strategic rationale was not available in the source material.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.